Playback speed
10 seconds
AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Heparin Monotherapy During Primary PCI in STEMI - The Randomized BRIGHT-4 Trial
By
AHA 2022 Conference Coverage
FEATURING
Gregg W. Stone
By
AHA 2022 Conference Coverage
FEATURING
Gregg W. Stone
1,587 views
November 14, 2022
Login to view comments.
Click here to Login